AHR and liver cancer: Using liver cancer cell lines and subcutaneous mice models, we demonstrated that Kyn produced by TDO2/Trp metabolism activated AhR/IL-6 pathway in liver cancer, eventually resulting in upregulation of the NF-kB/TIM4/STAT3 signals and cancer development.